SCYX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Scynexis Inc · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 4.84 USD
29.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -18.3% below the Trend Line and sits at 18.8% of its 52-week range. The latest completed week returned 29.8%, after a 9.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 66/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: earnings are due in 10d.

Setup score 33 out of 100
Latest Close 4.84 USD 31 Jul 2026
1W Return 29.8% latest completed week
4W Return 9.3% short-term follow-through
12W Return -33.9% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 3.0x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 29.8% Latest completed week; four-week move 9.3%. Indicator stack 7/34 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.01% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 66/100 conviction; expected move 35.1%. News sentiment 50/100 41 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -18.3% below the Trend Line and sits at 18.8% of its 52-week range. The latest completed week returned 29.8%, after a 9.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 3.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1512-week average 0.51

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 9.3% over four weeks, -33.9% over 12 weeks, and -11.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W29.8%
4W9.3%
12W-33.9%
26W-14.9%
52W-11.2%
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.00Latest activity-pressure read.
Pressure change18.3%Four-week change in activity pressure.
Leadership-27.37Latest relative-leadership reading.
RS change27.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value16/100Relative valuation strength. Underlying universe rank 85; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
14.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-2.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
101.3%
Gross profit retained from each unit of revenue.
Operating margin
-107.6%
Operating profit retained from revenue.
Free-cash-flow margin
-29.1%
Free cash flow generated from revenue.
Return on invested capital
-245.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
673.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

SCYX shows volatility options pressure with a 66/100 conviction score, put-call volume ratio of 0.16, expected move of 35.1%, and Sharemaestro trend signal inactive.

Conviction66/100
Expected move35.1%
Put/call volume0.16
Pressure82
Speculation98
Volatility96
Trend agreement0
Open options detail
Insider activity10 / 0

10 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 41 relevant articles.

3 positive · 34 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move35.1%Nearest-chain priced movement where available.
52-week drawdown-53.8%Distance below the 52-week high.
13-week volatility12.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+29.8%Week of 31 Jul.
Worst week-19.2%Week of 15 May.
Latest week+29.8%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains0
Flat weeks0
Modest losses6
Sharp losses10
Recent vol12.5%13-week weekly-return volatility.
Base vol11.4%52-week weekly-return volatility.
Up/down split20/31Count of positive and negative weeks in the 52-week window.
Average skew11.7% / -6.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis19/100

Latest 12-week confirmation: trend 2/12, activity pressure 2/12, relative leadership 0/12.

Activity pressure 0.15; No reversal markers Next-Week ExpectancyNegative 38.01%

Next-week expectancy is negative with a 38.01% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors9/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68; Small Cap Core rank 87 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options39/100

SCYX shows volatility options pressure with a 66/100 conviction score, put-call volume ratio of 0.16, expected move of 35.1%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 35.1% Sentiment50/100

Weighted news tone is neutral across 41 relevant articles.

Scynexis stock price target reiterated at $44.64 by Brookline Insiders10 / 0

10 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20264.84 USD29.8%5.92 USD10.49 USD-1.00-27.373.4MOff
24 Jul 20263.73 USD-12.6%5.93 USD10.60 USD-1.17-44.03379.0KOff
17 Jul 20264.27 USD-2.5%5.97 USD10.73 USD-1.17-37.56230.9KOff
10 Jul 20264.38 USD-1.1%5.99 USD10.86 USD-1.19-39.12518.4KOff
3 Jul 20264.43 USD15.1%6.02 USD10.97 USD-1.22-37.81498.5KOff
26 Jun 20263.85 USD-4.9%6.04 USD11.09 USD-1.27-45.94320.3KOff
19 Jun 20264.05 USD-4.3%6.10 USD11.21 USD-1.13-46.17469.9KOff
12 Jun 20264.23 USD-10.2%6.15 USD11.33 USD-0.96-42.89240.9KOff
5 Jun 20264.71 USD-16.5%6.16 USD11.44 USD-0.70-35.72436.9KOff
29 May 20265.64 USD-3.6%6.16 USD11.55 USD-0.26-27.462.5MOff
22 May 20265.85 USD-1.2%6.15 USD11.65 USD0.13-23.402.2MOn
15 May 20265.92 USD-19.2%6.16 USD11.74 USD0.54-22.122.1MOn
8 May 20267.33 USD-7.5%6.16 USD11.85 USD0.92-4.601.4MOn
1 May 20267.92 USD-2.9%6.13 USD11.95 USD1.087.851.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.